Fig. 4
From: Stem cell nebulization therapy for COVID-19 infection: radiological and clinical outcomes
Case 36: 58-year-old male with a history of hypertension, score 3 at the moment of inclusion. CT chest: a day of inclusion (April 11th). Bilateral multi-lobar multi-focal, peripheral and subpleural mixed attenuation groundglass, nodular, and linear opacities without crazy-paving pattern noted in bilateral lung parenchyma predominantly involving the bilateral lower lobes. b Day 8 after treatment on (April 21st, nebulization did on April 13th). A few scattered areas of ground-glass shadowing in the bilateral lungs. Significant resolution compared to the previous examination